ArticleBiomaterials research2022

Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression.

Jiajia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.